Page last updated: 2024-09-03

cholesta-5,8-dien-3 beta-ol and Disease Models, Animal

cholesta-5,8-dien-3 beta-ol has been researched along with Disease Models, Animal in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chevy, F; Citadelle, D; Kolf-Clauw, M; Mulliez, N; Pham, J; Roux, C; Wolf, C1
Batta, AK; Elias, ER; Honda, A; Irons, M; Salen, G; Shefer, S; Tint, GS; Xu, G1

Reviews

1 review(s) available for cholesta-5,8-dien-3 beta-ol and Disease Models, Animal

ArticleYear
The Smith-Lemli-Opitz syndrome: a potentially fatal birth defect caused by a block in the last enzymatic step in cholesterol biosynthesis.
    Sub-cellular biochemistry, 1997, Volume: 28

    Topics: Animals; Cholestadienols; Cholesterol; Dehydrocholesterols; Disease Models, Animal; Enzyme Inhibitors; Humans; Liver; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Piperazines; Smith-Lemli-Opitz Syndrome

1997

Other Studies

1 other study(ies) available for cholesta-5,8-dien-3 beta-ol and Disease Models, Animal

ArticleYear
Changes in serum sterols of rats treated with 7-dehydrocholesterol-delta 7-reductase inhibitors: comparison to levels in humans with Smith-Lemli-Opitz syndrome.
    Journal of lipid research, 1996, Volume: 37, Issue:6

    Topics: Animals; Child; Cholestadienols; Cholesterol; Dehydrocholesterols; Disease Models, Animal; Enzyme Inhibitors; Female; Heterozygote; Humans; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Piperazines; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Smith-Lemli-Opitz Syndrome; Sterols; trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride

1996